Date Range
Date Range
Date Range
We use cookies to enhance your experience. To visit this site you agree to our use of cookies. When you join Crisis y. In many parts of the U. A plan to end homelessness. Working with others, w. Online Gift Aid for past, present and future donations. Gift Card Terms and Conditions.
Reports Second Quarter 2015 Financial Results. Announces Conference Call to Discuss Second Quarter 2015 Results. There are currently no events scheduled.
Report of Organizational Actions - IRS form 8937. Friday, August 07, 2015. CubeSmart Second Quarter 2015 Earnings Call. Our strategy is to grow our property portfolio by being a consolidator in the highly fragmented self-storage industry. We believe these acquisitions will offer the Company economies of scale by spreading our management expertise and operating efficiency across a larger portfolio. We look to maximize the cash flow from our facil.
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. CUDC-907, an orally available small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with MYC-altered diffuse large B-cell lymphoma and in a Phase 1 trial in patients with MYC-altered solid tumors.
7 Million, Up 15 Percent from Prior Year. Cynosure to Host Second-Quarter 2015 Financial Results Conference Call on July 28.
PSoC 6 32-bit IoT MCUs. Traveo 32-bit ARM Auto MCUs. PSoC 32-bit ARM Cortex MCUs. USB Type-C and Power Delivery. 10 being Extremely likely, 5 being neutral and 0 being not likely at all.